Acid peptic disorder compass: An Indian expert consensus on comprehensive management

Figure 1  Flow chart representation of consensus development.

Figure 2 Diagnosis and treatment algorithm of gastroesophageal reflux disease. EE: Erosive esophagitis; ERD: Erosive reflux disease; GERD: Gastroesophageal reflux disease; NERD: Non-erosive reflux disease; RE: Reflux esophagitis; PCAB: Potassium-competitive acid blockers; PPI: Proton pump inhibitors; OD: Once-daily.

Figure 3 Diagnosis and treatment algorithm of peptic ulcer disease. AMX: Amoxicillin; GI: Gastrointestinal; H2RA: Histamine-H2 receptor antagonists; MET: Metronidazole; PUD: Peptic ulcer disease; PPI: Proton pump inhibitor; PCAB: Potassium-competitive acid blocker; TC: Tetracycline; H. pylori: Helicobacter pylori.

Figure 4 Diagnosis and treatment algorithm of functional dyspepsia. H2RA: Histamine-H2 receptor antagonists; PPI: Proton pump inhibitors; H. pylori: Helicobacter pylori.

Figure 5 Consensus recommendation on the acid peptic disorders 360° compass^©. PPI: Proton pump inhibitor; PCAB: Potassium-competitive acid blocker; H2RA: Histamine-H2 receptor antagonists; GI: Gastrointestinal; GERD: Gastroesophageal reflux disease; FD: Functional dyspepsia; PUD: Peptic ulcer disease; H. pylori: Helicobacter pylori; OD: Once a day; AMX: Amoxicillin; BD: Twice a day; NSAID: Non-steroidal anti-inflammatory drugs; TID-QID: Three times a day-four times a day; BID: Twice a day; QD: Once a day; BIS: Bismuth; TCA: Tricyclic antidepressant; FLQ: Fluoroquinolone; CBT: Cognitive behavioral therapy; SSRI/SNRI: Selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor. In the compass diagram, the innermost circle represents the condition, followed by rings depicting symptoms, alarm symptoms, diagnostic workup, and, in the outermost ring, the preferred treatment options in order of priority, arranged clockwise.